KOREA ETEX, Inc., headquartered in Seoul Korea, is a leading pharmaceutical company specialized in the development, manufacture, and marketing of generic and brand name pharmaceutical and medical products.

ILJIN Group took over the ETEX Corp. (Developer of BSM: Matrix-based bone substitute material), Cambridge Massachusetts, U.S.A., in 1990. With the factory of Squibb Pharmaceutical Corporation in Korea, KOREA ETEX started as the pharmaceutical division of the ILJIN Group.
The manufacturing plant complies with all FDA mandated Good Manufacturing Practice regulations, and stringent QA/QC procedures, ensuring KOREA ETEX's products are safe and effective.

KOREA ETEX's high quality products have been exported to Asian countries such as Vietnam, Cambodia and other countries as well.

Today, over 50 products are in the process of registration to meet strict standards of health authorities all over the world.

KOREA ETEX is committed to being a premier generic pharmaceutical company. This commitment to excellence is evident from its cutting edge research, development, and state-of-the-art manufacturing expertise with its unparalleled service and unsurpassed quality.